Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It primarily operates in Canada.
| Last: | $22.63 |
|---|---|
| Change Percent: | 11.92% |
| Open: | $20.27 |
| Close: | $20.22 |
| High: | $23.43 |
| Low: | $20.27 |
| Volume: | 38,239 |
| Last Trade Date Time: | 02/27/2026 12:44:32 pm |
| Market Cap: | $30,758,425 |
|---|---|
| Float: | 1,238,732 |
| Insiders Ownership: | 5.5% |
| Institutions: | 19 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.promisneurosciences.com |
| Country: | CA |
| City: | Toronto |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about ProMIS Neurosciences Inc. (NASDAQ: PMN).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
